Sartorius Stedim Biotech S.A. (VIE:DIM)

Market Cap	18.68B -7.9%
Revenue (ttm)	2.95B +7.7%
Net Income	263.90M +64.3%
EPS	2.71 +61.1%
Shares Out	n/a
PE Ratio	70.79
Forward PE	36.96
Dividend	0.69 (0.36%)
Ex-Dividend Date	Apr 2, 2025

Volume	n/a
Average Volume	n/a
Open	191.40
Previous Close	195.75
Day's Range	191.15 - 191.40
52-Week Range	151.15 - 234.70
Beta	n/a
RSI	42.60
Earnings Date	Feb 3, 2026

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 10,134
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DIM

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.